Innovative RNA Technologies AUM LifeTech specializes in next-generation RNA silencing products using FANA technology, offering superior alternatives to conventional gene editing methods like CRISPR. This positions the company as a leader for clients seeking cutting-edge genetic tools for therapeutic, agricultural, and research applications.

Diverse Market Applications The company's solutions are applicable across multiple sectors including biomedical research, medicine, agriculture, and aquaculture. This broad vertical focus creates opportunities to engage with pharmaceutical firms, biotech research centers, agricultural biotech companies, and pest management providers.

Recent Funding & Collaborations With recent $400K NIH SBIR grant funding and partnerships with institutions like Colorado State University and Boston Children's Hospital, AUM LifeTech demonstrates strong growth potential and collaborative opportunities that can be leveraged to expand sales channels and joint development projects.

Focus on Non-GMO Solutions AUM’s development of non-GMO RNA silencing products for disease and pest control in agriculture presents a compelling sales avenue for environmentally-conscious clients seeking sustainable and regulation-compliant solutions in crop protection and animal health.

Emerging Market Focus With a strategic emphasis on innovative genetic solutions for pressing health issues like COVID-19 and cancer immunotherapy, AUM LifeTech offers opportunities to connect with biotech and pharmaceutical companies seeking to expand their therapeutic pipelines with novel RNA-based treatments.